Atlas Trials

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

Clinical trial NCT07045142 · RECRUITING

Trial details

NCT number
NCT07045142
Sponsor
Central South University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2025-07-01
Primary completion
2027-12-31
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.